9 results
COVID-19 Lung POCUS 

This is a POCUS of a patient with COVID-19.
No prior pulmonary disease; had
COVID-19 Lung POCUS ... No prior pulmonary ... US: Irregular pleural ... #Clinical #Lung ... Ultrasound #SARSCoV2 #Coronavirus
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... ATS/STS/STR Clinical ... goals of assessing lung ... #Malignant #Pleural ... #Algorithm #Management
Fibrinous septations in Malignant Pleural Effusion (MPE) - Lung POCUS
 • can be triggered by thoracenteses
Pleural Effusion ... (MPE) - Lung POCUS ... #MPE #Lung #POCUS ... #clinical #ultrasound ... #pulmonary
COVID-19 - Subpleural Consolidations on Lung POCUS

Doing daily POCUS LUS for ICU COVID-19 patients in Singapore
Consolidations on Lung ... Helps with management ... conserve valuable PPEs ... #clinical #lung ... #ultrasound #pulmonary
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
ATS/STS/STR Clinical ... goals of assessing lung ... #Algorithm #Effusion ... #Malignant #Management ... #Pleural #Pulmonary
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... assay (IGRA) • PPD ... TB #Diagnosis #Management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... organ system: • Pleura ... tracheobronchial stenosis, malignancy ... assay (IGRA) • PPD ... TB #Diagnosis #Management
Preoperative Risk Evaluation

Major Pre-Op Questions:
1. Does the patient have any modifiable risk factors that could be
Evaluation Major Pre-Op ... algorithm to determine ... Change in clinical ... unless prior heart/lung ... medical and surgical management
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
salivary ducts Clinical ... Xerotrachea • NSIP: Pleural ... and Arthritis Malignancy ... MALT Lymphoma • Lung ... Rheumatology #Diagnosis #Management